Cochrane · systematic review · CD013309

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants

Galderisi, A, Trevisanuto, D, Russo, C, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Neonatal2 versionsAMSTAR 2: not assessed

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.

Questions

current version

GRADE rated

No studies

Included studies

No studies 6 · 85.7%Ungraded 0 · 0%Very low 1 · 14.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Summary of findings table ‐ Continuous glucose monitoring (CGM) compared to intermittent modalities for the prevention of morbidity and mortality in preterm infants at risk of hypoglycaemia or hyperglycaemia

Population: infants at risk of hypoglycaemia or hyperglycaemia

7 questions

Outcome	Effect	Evidence	Status / GRADE
Cerebral palsy ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies
Significant mental developmental delay ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies
Legal blindness ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies
Hearing deficit ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies
Neurodevelopmental impairment ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies
Death during initial hospitalization (all‐cause mortality) Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	RR 0.59 [0.16, 2.13]	2 studies · 230 participants	Very low Downgraded: risk of bias, imprecision
Neonatal seizures ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities	no estimate extracted	NR	No studies